Asahi Group Holdings would begin making minority investments in US start-ups from January 2023 through its Asahi Group Beverages & Innovation Fund which will open up new markets for low-alcohol and non-alcohol beverages.
The fund will support US start-ups that have "attractive brands" with significant future growth potential in the non-alcoholic beer-taste beverages, adult soft drink beverages, and low-alcohol categories.
It would also support start-ups with technology that leads to new sales and manufacturing methods, according to Atsushi Katsuki, president and CEO of Asahi Group Holdings.
Asahi will use its business platform to encourage sales growth for the goods and services offered by such enterprises both domestically and internationally.
By the end of 2025, the total investment is anticipated to be around $70 million. Employees recruited from the regional headquarters of Asahi Group will serve as the investment managers for Asahi Group Beverages & Innovation.


Mexico's Undervalued Equity Market Offers Long-Term Investment Potential
Ferrari Group to Launch IPO in Amsterdam, Targets Over $1 Billion Valuation
Dow Hits 50,000 as U.S. Stocks Stage Strong Rebound Amid AI Volatility
6 simple questions to tell if a ‘finfluencer’ is more flash than cash
SoftBank Eyes Up to $25B OpenAI Investment Amid AI Boom
Glastonbury is as popular than ever, but complaints about the lineup reveal its generational challenge
What’s the difference between baking powder and baking soda? It’s subtle, but significant
Global Markets Slide as AI, Crypto, and Precious Metals Face Heightened Volatility
Yen Slides as Japan Election Boosts Fiscal Stimulus Expectations
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
China's Refining Industry Faces Major Shakeup Amid Challenges
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
RBI Holds Repo Rate at 5.25% as India’s Growth Outlook Strengthens After U.S. Trade Deal
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Stuck in a creativity slump at work? Here are some surprising ways to get your spark back
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 



